
Search SNP
Search Gene
Search CNV
Search Haplotype
Search Other Variant
Search Region
Search Pathway
Search Study
Gene Report
Basic information | Related studies | Functional annotation | Related other genetic factors | Overlap with SZ and MDD | ADD to My Gene Set | Comment on Gene | View All Comments on Gene |
Approved Symbol | HTR2A |
---|---|
Previous Symbol | HTR2 |
Symbol Alias | 5-HT2A |
Approved Name | 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
Previous Name | 5-hydroxytryptamine (serotonin) receptor 2A |
Location | 13q14-q21 |
Position | chr13:46831550-46897076, -1 |
External Links |
HGNC: 5293 Entrez Gene: 3356 Ensembl: ENSG00000102468 UCSC: uc010acr.4 |
No. of Studies | 22 (Positive: 7; Negative: 15; trend: 0) |
Overlap with SZ? | YES |
Overlap with MDD? | YES |
Reference | Tested Markers | Statistical Values/Author Comments | Result Category | Comment on Study |
---|---|---|---|---|
McAuley, E. Z.,2009 | SNP: rs1923886, rs1928040, rs2224721, rs2770296, rs3125, rs6313, rs6314, rs985933 Haplotype: rs3125 - rs6314 - rs1923886 - rs2224721 - rs2770296() |
We found that HTR2A is associated with bipolar disorder. The HTR2A gene should not be excluded as a potential susceptibility gene for bipolar disorder despite a number of conflicting association results. | Positive | Comment on Study |
Kishi, T.,2009(b) | SNP: rs1928040, rs2070040, rs6313, rs7997012 Haplotype: rs6313 - rs2070040 - rs1928040 - rs7997012() |
In this study, we could detect no evidence of genetic association between 4 markers near HTR2A and MDD and BP, but sample sizes (especially BP) were probably too small to allow a meaningful test. | Negative | Comment on Study |
Choi, K. Y., 2010 | Other variant: 5-HT2A_promoter_1438A/G | There was a trend towards association between 5-HT2A -1438A/G polymorphism and psychotic symptom in bipolar disorder. | Positive | Comment on Study |
Etain, B.,2004 | Haplotype: (HTR2A_-1438G/A) - (HTR2A_His452Tyr)() Other variant: HTR2A_-1438A/G, HTR2A_His452Tyr |
Our study suggests that the 5HT2AR gene is unlikely to be involved in genetic susceptibility to BPAD but should be further investigated in a pharmacogenetic study. | Negative | Comment on Study |
Vincent, J. B.,1999(a) | Other variant: HTR2A_MspI Polymorphism, HTR2A_BbvI Polymorphism | Statistically significant positive associations were found in original Study. | Positive | Comment on Study |
Blairy, S.,2000 | Other variant: HTR2A_C102T | No contribution of the 5-HTR2a polymorphism on the bipolar disorder emerged. | Negative | Comment on Study |
Massat, I.,2000 | Other variant: HTR2A_C102T | These results indicate that, in our sample, the 5-HT2A receptor polymorphism studied is unlikely to play a major role in the genetic susceptibility to BPAD. | Negative | Comment on Study |
Lee, S. Y., 2012 | Other variant: HTR2A_-1438A/G | 5-HT2A-1438A/G A/A: P-value = 0.010, OR(95% CI)=3.13(1.31-7.49) in BP-I, P-value = 0.209, OR(95% CI)=1.48(0.80-2.74) in BP-II; 5-HT2A-1438A/G A/G: P-value = 0.019, OR(95% CI)=2.81(1.18-6.66) in BP-I, P-value = 0.165, OR(95% CI)=1.53(0.84-2.78) in BP-II. The regression showed a significant association of the 5-HT2A-1438A/G polymorphisms with BP-I only. | Positive | Comment on Study |
De Luca, V., 2007 | Other variant: HTR2A_C102T | There was no genetic association between HTR2A T102C with either schizophrenia or bipolar disorder under the assumption of a parent-of-origin effect. | Negative | Comment on Study |
Gu, L.,2013 | SNP: rs6311 | We failed to observe a significant association between HTR2A 21438A/G polymorphism and BD with any genetic model, and there were no statistically significant differences between Caucasians and Asians. | Negative | Comment on Study |
Arranz, M. J.,1997 | Other variant: HTR2A_C102T, HTR2A_516C/T, HTR2A_His452Tyr, HTR2A_Thr25Asn | No strong associations were found between any of these polymorphisms and bipolar affective disorder. Genetic variation at the 5-HT2A receptor gene does not play a major role in the pathogenesis of the disorder. | Negative | Comment on Study |
Xiang, B., 2013 | SNP: rs1475196, rs9567747 Haplotype: rs1928038 - rs1475196 - rs9562689 - rs9567747 - rs1328684 - rs1328684(C-A-G-A-G-G), rs1928038 - rs1475196 - rs9562689 - rs9567747 - rs1328684 - rs1328684(C-A-A-G-A-A), rs1928038 - rs1475196 - rs9562689 - rs9567747 - rs1328684 - rs1328684(G-A-G-G-A-A), rs1928038 - rs1475196 - rs9562689 - rs9567747 - rs1328684 - rs1328684(C-C-G-A-A-A), rs1928038 - rs1475196 - rs9562689 - rs9567747 - rs1328684 - rs1328684(C-A-G-A-A-A) |
Global P-value=0.003, X<sup>2</sup>=15.89, df=4. Our results indicate that the HTR2A gene in the serotonin pathway play important roles in susceptibility to BP-I. | Positive | Comment on Study |
Gutierrez, B.,1997(a) | Other variant: HTR2A_C102T, HTR2A_516C/T, HTR2A_His452Tyr, HTR2A_Thr25Asn | No significant association was observed between any of the four polymorphisms at the HTR2A locus, whether tested individually or as haplotypes, and bipolar affective disorder. The lack of association suggests that HTR2A is not a major risk factor for bipolar affective disorder. | Negative | Comment on Study |
Abdolmaleky, H. M.,2011 | Other variant: HTR2A_C102T | The allele frequency of the T102C polymorphism established no significant differences between the patients and controls.Epigenetic dysregulation of HTR2A may contribute to SCZ, BD and earlier age of disease onset. | Negative | Comment on Study |
Ni, X.,2002 | Haplotype: (5-HT2A_102T/C) - ( 5-HT2A_His452Tyr)((5-HT2A_102C)-(5-HT2A_452His)), (5-HT2A_102T/C) - ( 5-HT2A_His452Tyr)((5-HT2A_102C)-(5-HT2A_452Tyr)), (5-HT2A_102T/C) - ( 5-HT2A_His452Tyr)((5-HT2A_102T)-(5-HT2A_452His)), (5-HT2A_102T/C) - ( 5-HT2A_His452Tyr)((5-HT2A_102T)-(5-HT2A_452Tyr)) Other variant: 5-HT2A _T102C, 5-HT2A_His452Tyr |
At present, results of this study suggest that the 5-HT2A is unlikely to play a major role in the genetic susceptibility to BP. | Negative | Comment on Study |
Tan J., 2014 | SNP: rs6313 | The T102C polymorphism in HTR2A showed no association with BD. | Negative | Comment on Study |
Yosifova, A.,2009 | SNP: rs6313 | No SNP of this gene had significant association with BD in our population. | Negative | Comment on Study |
Fallin, M. D.,2005 | 9 SNP typed, Median D'=0.29, Median r<sup>2</sup> =0.01, 4 LD blocks, 0.61 block coverage, there exists SNP or haplotype nominal P-value > 0.01 and <0.05 in SZ/SZA and all SNP or haplotype P-value > 0.05 in BP.. This gene is suggestive to SZ/SZA , not suggestive to BP. | Negative | Comment on Study | |
Bonnier, B.,2002 | Other variant: HTR2A_-1438A/G | The association detected in this study suggests that the 5-HT(2A) receptor gene may play a role in the genetic susceptibility to bipolar disorder, through a specific subgroup of bipolar type I patients with lower risk of suicidal behavior. | Positive | Comment on Study |
Murphy, V. E.,2001 | Other variant: HTR2A_HpaII Polymorphism | No evidence was found for an association of 5HT-2A with bipolar affective disorder under the assumption of no imprinting and of imprinting. | Negative | Comment on Study |
Tut, T. G.,2000 | Other variant: HTR2A_C102T | Our finding indicates that the 5HTR2A receptor gene polymorphism is not a major factor in the genetic susceptibility to BPAD in Singaporean Chinese. | Negative | Comment on Study |
Ranade, S. S.,2003 | Other variant: HTR2A_1018578T/G, HTR2A_1018579A/G, HTR2A_1360020G/T, HTR2A_-1438A/G, HTR2A_1854352A/G, HTR2A_74C/A, HTR2A_C102T, HTR2A_1354C/T, HTR2A_516C/T | Our results support an etiological role for HTR2A in BD1. In view of the relatively small sample, replicate studies using large samples are needed. | Positive | Comment on Study |
GO terms by PBA (count: 3)

ID | Name | Type | Evidence[PMID] | No. of Genes in BDgene |
---|---|---|---|---|
GO:0005887 | integral component of plasma membrane | cellular component | IEA | 158 |
GO:0005886 | plasma membrane | cellular component | IDA[15862800]; TAS | 360 |
GO:0007268 | synaptic transmission | biological process | TAS[9109547] | 116 |
GO terms by database search (count: 44)

KEGG pathways by PBA (count: 2)

ID | Name | No. of Genes in BDgene | Brief Description |
---|---|---|---|
hsa04540 | Gap junction | 15 | |
hsa04020 | Calcium signaling pathway | 53 |
KEGG pathways by database search (count: 1)

ID | Name | No. of Genes in BDgene | Brief Description |
---|---|---|---|
hsa04080 | Neuroactive ligand-receptor interaction | 92 |
Gene | Interactor | Interactor in BDgene? | Experiment Type | PMID |
---|---|---|---|---|
HTR2A | ANKS1B | NO | yeast 2-hybrid | 16537434 |
HTR2A | NDUFB10 | NO | yeast 2-hybrid | 16537434 |
HTR2A | MAP1A | NO | yeast 2-hybrid | 16537434 |
HTR2A | JAK2 | NO | in vivo | 9169451 |
HTR2A | PPP5C | NO | yeast 2-hybrid | 16537434 |
HTR2A | DLG4 | NO | in vitro;in vivo | 12682061 |
HTR2A | RPS6KA3 | NO | in vitro;in vivo;yeast 2-hybrid | 16537434 |
HTR2A | GNAI1 | NO | in vivo | 11916537 |
HTR2A | MRPL28 | NO | yeast 2-hybrid | 16537434 |
HTR2A | NTRK3 | YES | yeast 2-hybrid | 16537434 |
HTR2A | GLUL | NO | yeast 2-hybrid | 16537434 |
HTR2A | NME3 | NO | yeast 2-hybrid | 16537434 |
HTR2A | EIF3F | NO | yeast 2-hybrid | 16537434 |
HTR2A | PON2 | NO | yeast 2-hybrid | 16537434 |
HTR2A | GNA11 | NO | in vivo | 11916537 |
HTR2A | GNAQ | NO | in vivo | 11916537 |
Literature-origin SNPs (count: 13)

rs_ID | Location | Functional Annotation | No. of Studies (Positive/Negative/Trend) ![]() |
---|---|---|---|
rs3125 | chr13:46834716 - 46834716(1) | 3_prime_UTR_variant | 1(0/1/0) |
rs7997012 | chr13:46837850 - 46837850(1) | intron_variant | 1(0/1/0) |
rs1475196 | chr13:46881488 - 46881488(1) | intron_variant | 1(1/0/0) |
rs2070040 | chr13:46893491 - 46893491(1) | downstream_gene_variant; intron_variant | 1(0/1/0) |
rs2224721 | chr13:46858019 - 46858019(1) | downstream_gene_variant; intron_variant | 1(1/0/0) |
rs985933 | chr13:46881728 - 46881728(1) | intron_variant | 1(0/1/0) |
rs6311 | chr13:46897343 - 46897343(1) | upstream_gene_variant | 1(0/1/0) |
rs2770296 | chr13:46866425 - 46866425(1) | intron_variant | 1(0/1/0) |
rs6314 | chr13:46834899 - 46834899(1) | missense_variant | 1(0/1/0) |
rs6313 | chr13:46895805 - 46895805(1) | intron_variant; synonymous_variant | 4(0/4/0) |
rs9567747 | chr13:46886479 - 46886479(1) | intron_variant | 1(1/0/0) |
rs1923886 | chr13:46849156 - 46849156(1) | intron_variant; upstream_gene_variant | 1(0/1/0) |
rs1928040 | chr13:46873101 - 46873101(1) | intron_variant | 2(0/2/0) |
LD-proxies (count: 39)

rs_ID | Literature-origin SNPs with LD | Location | Functional Annotation |
---|---|---|---|
rs3803189 | chr13:46834435 - 46834435(1) | 3_prime_UTR_variant | |
rs9567732 | chr13:46826872 - 46826872(1) | downstream_gene_variant | |
rs9567733 | chr13:46827200 - 46827200(1) | downstream_gene_variant | |
rs9595552 | chr13:46833295 - 46833295(1) | 3_prime_UTR_variant | |
rs4942587 | chr13:46888665 - 46888665(1) | intron_variant | |
rs2296973 | chr13:46892646 - 46892646(1) | downstream_gene_variant; intron_variant | |
rs2070037 | chr13:46892935 - 46892935(1) | downstream_gene_variant; intron_variant | |
rs9534511 | chr13:46894445 - 46894445(1) | downstream_gene_variant; intron_variant | |
rs1328683 | chr13:46884739 - 46884739(1) | intron_variant | |
rs2770297 | chr13:46872530 - 46872530(1) | intron_variant | |
rs2770298 | chr13:46872712 - 46872712(1) | intron_variant | |
rs972979 | chr13:46875029 - 46875029(1) | intron_variant | |
rs7323441 | chr13:46832493 - 46832493(1) | 3_prime_UTR_variant | |
rs1410657 | chr13:46874526 - 46874526(1) | intron_variant | |
rs7325168 | chr13:46832596 - 46832596(1) | 3_prime_UTR_variant | |
rs9316233 | chr13:46859220 - 46859220(1) | downstream_gene_variant; intron_variant | |
rs7324218 | chr13:46832821 - 46832821(1) | 3_prime_UTR_variant | |
rs985934 | chr13:46881590 - 46881590(1) | intron_variant | |
rs9526246 | chr13:46875726 - 46875726(1) | intron_variant | |
rs731245 | chr13:46898131 - 46898131(1) | upstream_gene_variant | |
rs4941570 | chr13:46865236 - 46865236(1) | intron_variant | |
rs6561336 | chr13:46873925 - 46873925(1) | intron_variant | |
rs4941575 | chr13:46901159 - 46901159(1) | upstream_gene_variant | |
rs732821 | chr13:46898744 - 46898744(1) | upstream_gene_variant | |
rs9534513 | chr13:46900003 - 46900003(1) | upstream_gene_variant | |
rs7324343 | chr13:46882290 - 46882290(1) | intron_variant | |
rs9562688 | chr13:46878414 - 46878414(1) | intron_variant | |
rs9567746 | chr13:46882413 - 46882413(1) | intron_variant | |
rs731779 | chr13:46877903 - 46877903(1) | intron_variant | |
rs9562687 | chr13:46877998 - 46877998(1) | intron_variant | |
rs9316235 | chr13:46871568 - 46871568(1) | intron_variant | |
rs927544 | chr13:46881916 - 46881916(1) | intron_variant | |
rs9526245 | chr13:46871832 - 46871832(1) | intron_variant | |
rs9567737 | chr13:46847131 - 46847131(1) | intron_variant | |
rs6561333 | chr13:46846177 - 46846177(1) | intron_variant | |
rs9567743 | chr13:46866665 - 46866665(1) | intron_variant | |
rs582854 | chr13:46871742 - 46871742(1) | intron_variant | |
rs2770293 | chr13:46864839 - 46864839(1) | intron_variant | |
rs4941573 | chr13:46890722 - 46890722(1) | downstream_gene_variant; intron_variant |
Variant Name | Variant Type | Location in Gene | No. of Studies (Positive/Negative/Trend) ![]() |
---|---|---|---|
HTR2A_1354C/T | point mutation | 1 (1/0/0) | |
HTR2A_1018579A/G | point mutation | 1 (0/1/0) | |
HTR2A_1018578T/G | point mutation | 1 (0/1/0) | |
HTR2A_516C/T | point mutation | 3 (1/2/0) | |
HTR2A_1854352A/G | point mutation | 1 (0/1/0) | |
HTR2A_-1438A/G | point mutation | 4 (1/3/0) | |
HTR2A_1360020G/T | point mutation | 1 (0/1/0) | |
HTR2A_His452Tyr | point mutation | 3 (0/3/0) | |
5-HT2A_His452Tyr | point mutation | in the intracellular C-terminal end of the 5-HT2A protein | 2 (1/1/0) |
HTR2A_C102T | point mutation | 8 (0/8/0) | |
5-HT2A_promoter_1438A/G | point mutation | promoter | 1 (1/0/0) |
HTR2A_BbvI Polymorphism | SNP | 1 (0/1/0) | |
5-HT2A _T102C | point mutation | 2 (0/2/0) | |
HTR2A_74C/A | point mutation | 1 (0/1/0) | |
HTR2A_Thr25Asn | point mutation | 2 (0/2/0) | |
HTR2A_MspI Polymorphism | SNP | 1 (1/0/0) | |
HTR2A_HpaII Polymorphism | point mutation | 1 (0/1/0) |
Region Name | Position | No. of Studies (Positive/Negative/Trend) ![]() |
---|---|---|
13q12-14 | chr13:18900000-54700000 | 1 (0/1/0) |
13q14 | chr13:39500000-54700000 | 3 (0/1/2) |
13q13-q14 | chr13:31600000-54700000 | 1 (1/0/0) |
Chr 13 | chr13:0-114364328 | 1 (0/0/1) |
Overlap with SZ from cross-disorder studies (count: 4)

Reference | Description | Result Category |
---|---|---|
21550210 | The allele frequency of the T102C polymorphism established no significant differences between the patients and controls.Epigenetic dysregulation of HTR2A may contribute to SCZ, BD and earlier age of disease onset. | Negative |
23404241 | Our results showed that the -1438A/G polymorphism was a risk factor for SZ, especially in Caucasians. | Positive |
24962835 | The T102C polymorphism in HTR2A showed no association with SZ. | Negative |
16380905 | This gene is suggestive to SZ/SZA , not suggestive to BP. | Trend |
Overlap with SZ from candidate gene intersection analysis (count: 58)

Reference | ID in SZGene | Result Category |
---|---|---|
9358020 | 293 | Positive |
11920856 | 293 | Negative |
8916101 | 293 | Negative |
11814537 | 293 | Negative |
11317227 | 293 | Trend |
19158809 | 293 | Negative |
12109966 | 293 | Negative |
9491814 | 293 | Negative |
9259371 | 293 | Negative |
10050975 | 293 | Negative |
11317226 | 293 | Negative |
8678105 | 293 | Positive |
17125970 | 293 | Trend |
19855357 | 293 | Positive |
14755448 | 293 | Negative |
11343865 | 293 | Negative |
17407792 | 293 | Negative |
15048642 | 293 | Negative |
9264136 | 293 | Negative |
17506229 | 293 | Negative |
10094133 | 293 | Negative |
8667937 | 293 | Negative |
8925254 | 293 | Negative |
8667938 | 293 | Negative |
17521439 | 293 | Negative |
10335553 | 293 | Negative |
10220013 | 293 | Negative |
7630250 | 293 | Negative |
17420819 | 293 | Negative |
12140776 | 293 | Positive |
8655141 | 293 | Positive |
20211215 | 293 | Negative |
18198266 | 293 | Negative |
15083167 | 293 | Positive |
8667941 | 293 | Negative |
17291660 | 293 | Negative |
10212557 | 293 | Trend |
11918989 | 293 | Negative |
9491812 | 293 | Negative |
12692777 | 293 | Negative |
20623453 | 293 | Positive |
8667939 | 293 | Negative |
17688403 | 293 | Negative |
8622505 | 293 | Positive |
18513383 | 293 | Positive |
9034001 | 293 | Negative |
9694252 | 293 | Negative |
12711403 | 293 | Negative |
15893580 | 293 | Negative |
17240119 | 293 | Positive |
12532038 | 293 | Positive |
16762472 | 293 | Positive |
16380905 | 293 | Trend |
10077731 | 293 | Negative |
10754425 | 293 | Negative |
15882913 | 293 | Negative |
17617023 | 293 | Positive |
8873116 | 293 | Negative |
Overlap with MDD from cross-disorder studies (count: 4)

Reference | Description | Category in MDD |
---|---|---|
19428704 | In this study, we could detect no evidence of genetic association between 4 markers near HTR2A and MDD and BP, but sample sizes(especially BP) were probably too small to allow a meaningful test. | Negative |
11983190 | The 5-HT2A receptor gene may play some role in mood disorders. | Negative |
24962835 | The T102C polymorphism in HTR2A showed no association with MDD. | Negative |
23404241 | The results indicated that the HTR2A 21438A/G polymorphism was not associated with MDD in Caucasians in all genetic models. | Negative |
Overlap with MDD from candidate gene intersection analysis (count: 7)

Reference | Description | Category in MDD | Link in MK4MDD |
---|---|---|---|
10686553 | The major finding of this study was a significant association between the 102 C allele in 5-HT2A receptor gene and major depression, chi(2) = 4.5, df = 1, P = 0.03, particularly in patients with suicidal ideation, chi(2) = 8.5, df = 1, P < 0.005. | Pos | HTR2A |
14730199 | This polymorphism was analyzed in 189 patients with MDD and in 148 unrelated healthy controls using a case-control design, which revealed a significant difference in the genotype distributions (chi(2) = 10.78, d.f. = 2, p = 0.005). The frequency of the -1438G allele was also much higher in MDD patients than in normal controls (chi(2) = 7.20, p = 0.007; OR = 1.52, 95% CI 1.12-2.06). We also found significantly more carriers of the G allele (GG+AG genotypes) in MDD patients than in normal controls (chi(2) = 10.18, p = 0.001; OR = 2.46, 95% CI 1.40-4.32). | Pos | HTR2A |
17938633 | Selected differentially expressed genes in BA44 to BA47 (ANOVA and t-test P < 0.01, fold change 1.3t) | Pos | HTR2A |
18502553 | There were no significant differences in the genotype distributions or allelic frequencies in the two serotonergic polymorphisms between suicide attempters and normal controls. None of the two serotonergic polymorphisms was correlated with lethality. | Neg | HTR2A |
11803534 | Significant differences in allele (chi-square = 4.13, df = 1, P = 0.04) and genotype (chi-square = 6.19, df = 2, P = 0.04) distributions were found between non-suicide attempters and suicide attempters. Moreover, those patients carrying 5-HT(2A)-C allele had more than five times the risk for attempting suicide than noncarriers (OR = 5.50, 95% CI = 1.18-35.20, P = 0.01). | Pos | HTR2A |
20471034 | We also observed that variations in other mRNA expression were associated with treatment efficacy or clinical improvement (CREB1, HDAC5, HSPA2, HTR1B, HTR2A, and SLC6A4/5HTT). | Pos | HTR2A |
Region: chr13:46831550..46897076 View in gBrowse
Copyright: Bioinformatics Lab, Institute of Psychology, Chinese Academy of Sciences Feedback
Acknowledgements
To view this website normally, please make sure to allow Flash to run from the local filesystem in the security settings panel.
Last update: March 31, 2016